Sam Slutsky

Stock Analyst at LifeSci Capital

(0.89)
# 3,798
Out of 4,944 analysts
3
Total ratings
66.67%
Success rate
-18.27%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Sam Slutsky

Palvella Therapeutics
Aug 4, 2025
Initiates: Outperform
Price Target: $90
Current: $42.57
Upside: +111.42%
ABIVAX Société Anonyme
Jul 23, 2025
Maintains: Outperform
Price Target: $45$101
Current: $69.63
Upside: +45.05%
InflaRx
Apr 5, 2023
Upgrades: Outperform
Price Target: n/a
Current: $0.79
Upside: -